User profiles for O. Delattre
Olivier DelattreInserm-Institut Curie Verified email at curie.fr Cited by 56242 |
[PDF][PDF] Ewing sarcoma: current management and future approaches through collaboration
…, H Kovar, R Grimer, J Whelan, L Claude, O Delattre… - J Clin …, 2015 - researchgate.net
… Schleiermacher G, Delattre O: Detection of micrometastases and circulating tumour cells
using molecular biology technics in solid tumours [in French]. Bull Cancer 88:561-570, 2001 47. …
using molecular biology technics in solid tumours [in French]. Bull Cancer 88:561-570, 2001 47. …
Ewing sarcoma
Ewing sarcoma is the second most frequent bone tumour of childhood and adolescence that
can also arise in soft tissue. Ewing sarcoma is a highly aggressive cancer, with a survival of …
can also arise in soft tissue. Ewing sarcoma is a highly aggressive cancer, with a survival of …
SWI/SNF chromatin remodeling and human malignancies
…, F Bourdeaut, O Delattre - Annual Review of …, 2015 - annualreviews.org
The SWI/SNF complexes, initially identified in yeast 20 years ago, are a family of multi-subunit
complexes that use the energy of adenosine triphosphate (ATP) hydrolysis to remodel …
complexes that use the energy of adenosine triphosphate (ATP) hydrolysis to remodel …
Systematic identification of genomic markers of drug sensitivity in cancer cells
…, I Stamenkovic, JA Engelman, SV Sharma, O Delattre… - Nature, 2012 - nature.com
Clinical responses to anticancer therapies are often restricted to a subset of patients. In some
cases, mutated cancer genes are potent biomarkers for responses to targeted agents. Here…
cases, mutated cancer genes are potent biomarkers for responses to targeted agents. Here…
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
EWING'S sarcoma and related subtypes of primitive neuroectodermal tumours share a recurrent
and specific t(ll;22) (q24;q12) chromosome translocation 1–8 , the breakpoints of which …
and specific t(ll;22) (q24;q12) chromosome translocation 1–8 , the breakpoints of which …
Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2
…, P Jong, D Parry, R Eldrige, A Aurias, O Delattre… - Nature, 1993 - nature.com
… radixin: a large N-terminal domain followed by a large o-helix domain and a small C terminus.
… From these homologies we predict that the N-terminal domain binds to integrins and the o- …
… From these homologies we predict that the N-terminal domain binds to integrins and the o- …
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
…, P Ambros, R Handgretinger, A Aurias, O Delattre - Nature, 1998 - nature.com
Malignant rhabdoid tumours (MRTs) are extremely aggressive cancers of early childhood.
They can occur in various locations, mainly the kidney, brain and soft tissues 1 , 2 . …
They can occur in various locations, mainly the kidney, brain and soft tissues 1 , 2 . …
[HTML][HTML] Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and …
…, ML Bäcklund, C Haberler, F Bourdeaut, O Delattre… - Acta …, 2012 - Springer
Medulloblastoma is the most common malignant brain tumor in childhood. Molecular studies
from several groups around the world demonstrated that medulloblastoma is not one …
from several groups around the world demonstrated that medulloblastoma is not one …
[HTML][HTML] Subgroup-specific structural variation across 1,000 medulloblastoma genomes
…, M Perek-Polnik, CC Haberler, O Delattre… - Nature, 2012 - nature.com
Medulloblastoma, the most common malignant paediatric brain tumour, is currently treated
with nonspecific cytotoxic therapies including surgery, whole-brain radiation, and aggressive …
with nonspecific cytotoxic therapies including surgery, whole-brain radiation, and aggressive …
[PDF][PDF] Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition
Smoothened (SMO) inhibitors recently entered clinical trials for sonic-hedgehog-driven
medulloblastoma (SHH-MB). Clinical response is highly variable. To understand the mechanism(…
medulloblastoma (SHH-MB). Clinical response is highly variable. To understand the mechanism(…